|
Re: Gilead GS-5829 Perspective
|
1
|
Zenith Epigenetics
|
Jul 24, 2017 10:51AM
|
|
Re: General chances of success
|
4
|
Resverlogix Corp.
|
Feb 06, 2019 01:01PM
|
|
Re: Gasoline
|
1
|
Zenith Epigenetics
|
Jan 30, 2017 07:44PM
|
|
Re: Gasoline
|
|
Zenith Epigenetics
|
Jan 30, 2017 07:57PM
|
|
Re: Gasoline
|
4
|
Zenith Epigenetics
|
Jan 30, 2017 09:29PM
|
|
Re: Gasoline
|
4
|
Zenith Epigenetics
|
Jan 31, 2017 03:03PM
|
|
Re: Gasoline
|
3
|
Zenith Epigenetics
|
Feb 05, 2017 01:11PM
|
|
Re: Gasoline
|
3
|
Zenith Epigenetics
|
Jan 30, 2017 12:57PM
|
|
Re: Gasoline
|
3
|
Zenith Epigenetics
|
Feb 05, 2017 08:21PM
|
|
Re: Games being played on the share price
|
1
|
Resverlogix Corp.
|
May 02, 2019 01:18AM
|
|
Re: Games being played on the share price
|
3
|
Resverlogix Corp.
|
May 01, 2019 12:45PM
|
|
Re: Games being played on the share price
|
2
|
Resverlogix Corp.
|
May 01, 2019 12:54PM
|
|
Re: Games being played on the share price
|
1
|
Resverlogix Corp.
|
May 01, 2019 04:18PM
|
|
Re: FXR and liver transaminase related adverse events
|
1
|
Resverlogix Corp.
|
Oct 03, 2018 12:10PM
|
|
Re: FXR and liver transaminase related adverse events
|
3
|
Resverlogix Corp.
|
Oct 03, 2018 02:55PM
|
|
Re: Funny how,...
|
2
|
Resverlogix Corp.
|
Dec 24, 2019 12:11PM
|
|
Re: Funding
|
2
|
Resverlogix Corp.
|
Jun 23, 2017 02:49PM
|
|
Re: Fun with Numbers
|
2
|
Resverlogix Corp.
|
Oct 18, 2022 01:43PM
|
|
Re: Fun and games?
|
2
|
Resverlogix Corp.
|
Jun 24, 2019 02:19PM
|
|
Re: From the NKF Facebook Page...
|
5
|
Resverlogix Corp.
|
Feb 25, 2020 07:00PM
|
